Clinical Trial Update: Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating infliximab in combination with methotrexate for rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Infliximab (Remicade) (Infliximab)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Centocor, Inc. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED